AK5: Adenylate Kinase 5 – Key Regulator of Cellular Energy Metabolism

Comprehensive genomic, transcriptomic, and proteomic analysis of AK5, including expression, mutations, and disease associations.

Gene Information Card

Symbol AK5
Full Name Adenylate Kinase 5
Gene Type Protein coding
Chromosomal Location 1p31.1
NCBI Gene ID 26289 ncbi.nlm.nih.gov/gene/26289
Ensembl ID ENSG00000117525
UniProt ID Q9Y6K8
OMIM ID 608907
HGNC ID 363
Aliases AK6, AKL, AK5L, C1orf64

Description

AK5 (Adenylate Kinase 5) encodes a member of the adenylate kinase family, enzymes that catalyze the reversible transfer of a phosphate group between ATP and AMP, thereby maintaining cellular energy homeostasis. AK5 is localized to the cytoplasm and is involved in nucleotide metabolism, particularly in tissues with high energy demand. The gene spans approximately 30 kb on chromosome 1p31.1 and contains 10 exons. Alternative splicing generates multiple transcript variants.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Colorectal Cancer Altered AK5 expression may disrupt ATP/AMP balance, promoting tumor cell proliferation COSMIC, NCBI Gene
Breast Cancer Dysregulation of AK5 linked to metabolic reprogramming in cancer cells COSMIC
Lung Cancer Somatic mutations in AK5 observed in lung adenocarcinoma COSMIC
Glioma AK5 expression changes associated with aggressive tumor phenotypes NCBI Gene, COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Brain 12.3 Medium
Heart 8.7 Medium
Liver 4.2 Low
Kidney 6.1 Low
Testis 15.8 High
Skeletal Muscle 9.5 Medium
Cell Line Expression
Cell Line nTPM Notes
HEK293 10.2 Embryonic kidney, moderate expression
HeLa 7.8 Cervical carcinoma, moderate expression
A549 5.4 Lung carcinoma, low expression
MCF7 6.9 Breast carcinoma, low expression
SH-SY5Y 14.1 Neuroblastoma, high expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
p.Gly56Arg Missense <0.01% Unknown functional impact
p.Arg102Trp Missense <0.01% Potential loss of catalytic activity
c.345+1G>A Splice donor <0.01% Likely disrupts splicing
p.Glu198Lys Missense <0.01% Unknown functional impact
Mutation functional classification

Loss of Function (LOF)

Splice-site and missense mutations that impair catalytic activity or protein stability are predicted to reduce adenylate kinase function.

Gain of Function (GOF)

No gain-of-function mutations have been reported for AK5.

Dominant Negative (DN)

No dominant-negative mutations have been characterized for AK5.

Gene Ontology (GO)

• GO:0004017 – adenylate kinase activity • GO:0005524 – ATP binding
• GO:0006172 – ADP biosynthetic process • GO:0046034 – ATP metabolic process
• GO:0005737 – cytoplasm

Pathways

Purine metabolism (Reactome: R-HSA-73847)
Adenine nucleotide interconversion (Reactome: R-HSA-8956319)

Protein Summary

AK5 is a 198-amino-acid protein (UniProt Q9Y6K8) belonging to the adenylate kinase family. It catalyzes the reversible conversion of ATP + AMP to 2 ADP, playing a crucial role in cellular energy homeostasis. The protein contains a conserved NMP kinase domain and is predominantly expressed in brain and testis. Structural studies indicate a typical α/β fold with a central β-sheet flanked by α-helices. AK5 is implicated in nucleotide metabolism and may influence cell proliferation in cancer.

Related Products

Product name Cat.No. Species Gene ID
PAK5 Knockout HEK293 Cell Line EDJ-KQ1240 Human 57144 Details Get a Quote
AK5 Knockout HEK293 Cell Line EDJ-KQ8508 Human 26289 Details Get a Quote
AK5 Knockout A-549 Cell Line EDJ-KQ34633 Human 26289 Details Get a Quote
AK5 Knockout HeLa Cell Line EDJ-KQ55924 Human 26289 Details Get a Quote
PAK5 Knockout HeLa Cell Line EDJ-KQ56813 Human 57144 Details Get a Quote
PAK5 Knockout A-549 Cell Line EDJ-KQ65321 Human 57144 Details Get a Quote
AK5 Knockout HCT 116 Cell Line EDJ-KQ72866 Human 26289 Details Get a Quote
PAK5 Knockout HCT 116 Cell Line EDJ-KQ73757 Human 57144 Details Get a Quote
Displaying Records 1 To 8 Of 8 Records
Contact Us
*
*
*
*
How did you hear about us: